ArticleBMC public health2025
Prevalence and determinants of HIV testing among adolescent girls and young women in 28 sub-Saharan African countries.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHIV and AIDS remain a major global public health issue with the largest burden in sub-Saharan African (SSA) (SSA) countries. Adolescent girls and young women (AGYW) in the sub-Saharan African region experience intersecting vulnerabilities that may increase their exposure to HIV, while also constraining their engagement with treatment and care. HIV testing is crucial in the AIDS response for both prevention and treatment, therefore, necessitating understanding of HIV testing practices, especially among priority populations. We examined HIV testing and associated factors among AGYW (15–24 years) in 28 SSA countries.
methodsWe analysed Demographic and Health Survey datasets from 28 SSA countries from 2010–2022 focusing on data collected from AGYW aged 15–24 (n=58,263) who had screened for HIV in the last survey conducted in each country. We merged all weighted datasets from 28 countries to generate the prevalence of HIV testing among AGYW in each country and to provide an overall prevalence in SSA. We then conducted bivariate and multivariable binary logistic regression analysis to examine factors associated with HIV testing and presented the results in crude odds ratio [cOR] and adjusted odds ratio [aOR] with corresponding confidence intervals (CIs).
resultsOur results showed that the overall prevalence of HIV testing among AGYW across the 28 SSA countries was 63%, with Zambia and Mali having the highest and lowest prevalence at 76% 6.70% respectively. Being in the age bracket 20–24 [aOR=2.22, 95% CI=2.08–2.37], comprehensive HIV knowledge [aOR=3.76, 95% CI=2.60–5.43], higher formal education [aOR=2.23, 95% CI=2.02–2.46], and three and above lifetime sexual partners [aOR=1.41, 95% CI=1.29–1.55] were all associated with HIV testing. Also, past year experience of STI [aOR=1.25, 95% CI=1.11–1.41], being employed [aOR=1.08, 95% CI=1.02–1.16], pregnancy history [aOR=1.09, 95% CI=1.03–1.14], high household wealth index [aOR=2.26, 95% CI=1.97–2.59] and being in a union [aOR=3.23, 95% CI=2.97–3.51] were associated with HIV testing.
conclusionConcerningly, 21 countries, representing 75% of the countries included in the current study, have HIV testing coverage below 50% for AGYW. Collaborative efforts are needed to fast-track HIV screening/testing for AGYW considering their disproportionate vulnerability to HIV exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.